Products/Services Used | Details | Operation |
---|---|---|
Gene Synthesis> | In brief, the gene encoding the catalytic domain of human EPHA2 (residues D596-G900) was synthesized at GenScript USA Inc., USA and was optimized for its expression in insect cells. Synthesized EPHA2 gene was sub-cloned in pTriEx 1.1 with cleavable N-terminal Flag-His tag. Recombinant baculovirus incorporating the kinase cDNA construct was generated by homologous recombination with BacMagic DNA (Novagen), in Spodoptera frugiperda (Sf9) cells | Get A Quote |
The receptor tyrosine kinase EPHA2 has gained interest as therapeutic drug target in cancer and infectious diseases. However, EPHA2 research and EPHA2-based therapies have been hampered by the lack of selective small molecule inhibitors. Here, we report on the synthesis and evaluation of dedicated EPHA2 inhibitors based on the clinical BCR-ABL/SRC inhibitor Dasatinib as a lead structure. We designed hybrid structures of Dasatinib and the previously known EPHA2 binders CHEMBL249097, PD-173955 and a known EPHB4 inhibitor in order to exploit both the ATP pocket entrance as well as the ribose pocket as binding epitopes in the kinase EPHA2. Medicinal chemistry and inhibitor design was guided by a chemical proteomic ... More